Term Name: norverapamil
Synonyms: (+-)-norverapamil, (RS)-2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-2-(propan-2-yl)pentanenitrile, (RS)-norverapamil, 5-((3,4-Dimethoxyphenethyl)amino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile, alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)amino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile, desmethylverapamil, rac-2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-2-(propan-2-yl)pentanenitrile, rac-norverapamil
Definition: A racemate comprising equimolar amounts of (R)- and (S)-norverapamil. The major active metabolite of verapamil.
Ontology: ChEBI [CHEBI:132050]  ( EBI )

Relationships
is a type of: racemate
has_part: (R)-norverapamil (S)-norverapamil
has_role: anti-arrhythmia drug antihypertensive agent calcium channel blocker drug metabolite EC 1.2.3.1 (aldehyde oxidase) inhibitor EC 3.4.24.18 (meprin A) inhibitor EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor EC 3.6.3.1 (phospholipid-translocating ATPase) inhibitor EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor environmental contaminant vasodilator agent xenobiotic